Stay updated with breaking news from Suzanne Cuda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A tiny but quickly increasing proportion of American teenagers started taking Novo Nordisk's NONOb.CO weight-loss medication Wegovy last year which is being considered a potent new tool to combat...
In March last year, Billy Small Jr. of Oakland, California, was on the cusp of developing type 2 diabetes, weighing in at 385 pounds (176 kilograms) - twice that of the average boy his age.
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's <NOVOb.CO> weight-loss drug Wegovy last year, a powerful new tool to address...
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according to data shared exclusively with Reuters.
By Robin Respaut and Chad Terhune (Reuters) - A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according ...